Detection of mitochondrial DNA mutations in T cells following 5-FU or cisplatin exposure
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 38 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Samples
- 38 samples: 34 distinct titles, 2 of them repeatedGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Detection of mitochondrial DNA mutations in T cells following 5-FU or cisplatin exposureCell reports. Medicine · 2026
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE310683_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1366936 and SRA study SRP647240. Searching any of these in the dataset finder brings you back here.
How we read this: Read from 38 sample titles: 34 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9306652 T cells from donor D1007, untreated (N), GEX
- GSM9306653 T cells from donor D1007, untreated (N), TCR
- GSM9306654 T cells from donor D1007, 5-FU-treated, GEX
- GSM9306655 T cells from donor D1007, 5-FU-treated, TCR
- GSM9306656 T cells from donor D2008, untreated (N), GEX
- GSM9306657 T cells from donor D2008, untreated (N), TCR
- GSM9306658 T cells from donor D2008, 5-FU-treated, GEX
- GSM9306659 T cells from donor D2008, 5-FU-treated, TCR
- GSM9306660 T cells from donor D6053, untreated (N), GEX
- GSM9306661 T cells from donor D6053, untreated (N), TCR
- GSM9306662 T cells from donor D6053, 5-FU-treated, GEX
- GSM9306663 T cells from donor D6053, 5-FU-treated, TCR
- GSM9306664 T cells from donor D1007, untreated (N), ATAC
- GSM9306665 T cells from donor D1007, 5-FU-treated, ATAC
- GSM9306666 T cells from donor D2008, untreated (N), ATAC
- GSM9306667 T cells from donor D2008, 5-FU-treated, ATAC
- GSM9306668 T cells from donor D6053, untreated (N), ATAC
- GSM9306669 T cells from donor D6053, 5-FU-treated, ATAC
- GSM9306670 T cells from donor D0010, untreated (N), ATAC
- GSM9306671 T cells from donor D0010, 5-FU-treated, ATAC
- GSM9306672 T cells from donor D1007, without cisplatin (NC), ATAC
- GSM9306673 T cells from donor D1007, cisplatin(CIS)-treated, ATAC
- GSM9306674 T cells from donor D2008, without cisplatin (NC), ATAC
- GSM9306675 T cells from donor D2008, cisplatin(CIS)-treated, ATAC
- GSM9306676 T cells from donor D6053, without cisplatin (NC), ATAC
- GSM9306677 T cells from donor D6053, cisplatin(CIS)-treated, ATAC
- GSM9306678 T cells from donor D1007, cisplatin(CIS)-treated TMRM high, ATAC
- GSM9306679 T cells from donor D1007, cisplatin(CIS)-treated TMRM low, ATAC
- GSM9306680 T cells from donor D2008, cisplatin(CIS)-treated TMRM high, ATAC
- GSM9306681 T cells from donor D2008, cisplatin(CIS)-treated TMRM low, ATAC
- GSM9306682 T cells from donor D1007, cisplatin(CIS)-treated MASS high, ATAC
- GSM9306683 T cells from donor D1007, cisplatin(CIS)-treated MASS low, ATAC
- GSM9306684 TIL from P1
- GSM9306685 PBL from P1
- GSM9306686 TIL from P2
- GSM9306687 PBL from P2
- GSM9306688 TIL from P3
- GSM9306689 PBL from P3
- GSE234558 Tracking rare single donor and recipient immune and leukemia cells after allogeneic hematopoietic cell transplantation using mitochondrial DNA mutations 85 samples shares mitochondrial, mutations
- GSE342354 Time-series RNA-seq of U2OS cells following CCCP-induced mitochondrial damage and recovery upon drug washout 12 samples shares mitochondrial, following
- GSE317520 Mitochondrial DNA Mutations Drive Tumor Heterogeneity in Papillary Thyroid Carcinoma 92 samples shares mitochondrial, mutations
- GSE234552 Tracking of donor and recipient immune and leukemia phenotypes after allogeneic stem cell transplantation using mitochondrial DNA mutations. [ASAP-Seq 2] 30 samples shares mitochondrial, mutations
- GSE234555 Tracking of donor and recipient immune and leukemia phenotypes after allogeneic stem cell transplantation using mitochondrial DNA mutations. [ASAP-Seq 3] 14 samples shares mitochondrial, mutations
- GSE234556 Tracking of donor and recipient immune and leukemia phenotypes after allogeneic stem cell transplantation using mitochondrial DNA mutations. [Tapestri] 10 samples shares mitochondrial, mutations
- GSE234551 Tracking of donor and recipient immune and leukemia phenotypes after allogeneic stem cell transplantation using mitochondrial DNA mutations. [ASAP-Seq 1] 9 samples shares mitochondrial, mutations
- GSE325486 ESR1 mutations shape the clonal dynamics, genetic diversity and cellular states of acquired resistance to CDK4/6 inhibitors 57 samples shares mutations
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.